Advertisement
The Scientist
The Scientist

The Scientist

» business

Most Recent

image: Scripps’s President Steps Down

Scripps’s President Steps Down

By | July 23, 2014

Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.

1 Comment

image: AbbVie Buys Shire for $54 Billion

AbbVie Buys Shire for $54 Billion

By | July 21, 2014

The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.

0 Comments

image: 2014 Salary Survey Closed

2014 Salary Survey Closed

By | July 14, 2014

Check back for the results in November!

3 Comments

image: Agencies Partner to Help Commercialize Biomedical Discoveries

Agencies Partner to Help Commercialize Biomedical Discoveries

By | June 19, 2014

Collaborative effort from the US National Science Foundation and National Institutes of Health offers business training for federally funded researchers.

0 Comments

image: Pharma Buyout Tabled

Pharma Buyout Tabled

By | May 27, 2014

Pfizer says it won’t continue its pursuit to purchase AstraZeneca—at least for now.

0 Comments

image: Novartis and Glaxo Agree to Big Deal

Novartis and Glaxo Agree to Big Deal

By | April 22, 2014

The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.

2 Comments

image: Biotech Superstar Dies

Biotech Superstar Dies

By | March 7, 2014

Alejandro Zaffaroni, who launched companies that developed birth control pills, microarrays, and transdermal drug patches, has died at age 91.  

0 Comments

image: Guidelines for Gene Patent Ruling

Guidelines for Gene Patent Ruling

By | March 7, 2014

The USPTO offers guidance to its patent examiners on how to interpret the Supreme Court’s rulings in the recent Myriad and Prometheus cases.

0 Comments

image: Incubator Boom

Incubator Boom

By | March 1, 2014

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?  

1 Comment

image: Stem Cell Trials in Peril?

Stem Cell Trials in Peril?

By | January 27, 2014

The only US firm with an ongoing embryonic stem cell therapy clinical trial is in financial and legal hot water.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
NeuroScientistNews
NeuroScientistNews

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist